Page breadcrumb nav

VAERS Report 2157153

Case Report Section

Détails du rapport Vaer

Âge: 6 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fn4071


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-07
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

rash red flushed cheeks; rash red flushed cheeks; felt hot; complained of a stiff neck since; its affecting life, in school and at home; cheeks went very red straight after the vaccine; irritable; quiet sleepy/ very sleepy at times; not herself/ not herself at all; feeling unwell; 6-year-old female patient received bnt162b2 (comirnaty) as dose 1, single, 10 micrograms/dose for covid-19 immunisation; this is a spontaneous report received from a contactable reporter (consumer or other non hcp) from the regulatory authority. regulatory number: ie-ra-2022-092509 (ra). other case identifier(s): ie-ra-cvarr2022020725733 (ra). a 6-year-old female patient received bnt162b2 (comirnaty), administration date 07feb2022 (lot number: fn4071) at the age of 6 years as dose 1, 10 ug single for covid-19 immunisation. the patient's relevant medical history was not reported. there were no concomitant medications. the following information was reported: rash (medically significant), flushing (medically significant) all with onset 07feb2022, outcome "recovered" and all described as "rash red flushed cheeks"; feeling hot (medically significant) with onset 07feb2022, outcome "not recovered", described as "felt hot"; musculoskeletal stiffness (medically significant) with onset 07feb2022, outcome "not recovered", described as "complained of a stiff neck since"; loss of personal independence in daily activities (medically significant) with onset 07feb2022, outcome "not recovered", described as "its affecting life, in school and at home"; erythema (medically significant) with onset 07feb2022, outcome "recovered", described as "cheeks went very red straight after the vaccine"; irritability (medically significant) with onset 07feb2022, outcome "not recovered", described as "irritable"; somnolence (medically significant) with onset 07feb2022, outcome "not recovered", described as "quiet sleepy/ very sleepy at times"; feeling abnormal (medically significant) with onset 07feb2022, outcome "not recovered", described as "not herself/ not herself at all"; malaise (medically significant) with onset 07feb2022, outcome "not recovered", described as "feeling unwell"; product administered to patient of inappropriate age (non-serious) with onset 07feb2022, outcome "unknown", described as "6-year-old female patient received bnt162b2 (comirnaty) as dose 1, single, 10 micrograms/dose for covid-19 immunisation". the events "rash red flushed cheeks", "rash red flushed cheeks", "felt hot", "complained of a stiff neck since", "its affecting life, in school and at home", "cheeks went very red straight after the vaccine", "irritable", "quiet sleepy/ very sleepy at times", "not herself/ not herself at all" and "feeling unwell" were evaluated at the physician office visit. therapeutic measures were taken as a result of rash, flushing, feeling hot, musculoskeletal stiffness, loss of personal independence in daily activities, erythema, irritability, somnolence, feeling abnormal, malaise. clinical course: the reporter stated that she could not remember exactly, but the patient had another vaccine (unspecified) from the school a while ago. one that all school kids her age were due at that time. on 07feb2022, the patient was vaccinated with the first dose of comirnaty 10 micrograms/dose concentrate for dispersion for injection (batch number: fn4071). thirty minutes later, on 07feb2022, the patient experienced rash red flushed cheeks (cheeks went very red straight after the vaccine) and she felt hot. she was quite sleepy, irritable and not herself. the patient complained of a stiff neck since and not feeling well in herself. it was reported that it was affecting her life, in school and at home. even her teacher noticed a difference in her. the clinical lead in the vaccination centre recommended not to give her the second dose and to contact the general practitioner (gp). the gp said that the patient should have the second dose, to protect her. the patient was treated with calpol. no follow-up attempts are possible. no further information is expected. sender's comments: linked report(s) : ie-hpra-2022-092511

Données de laboratoire
na
Liste des symptômes
malaise feeling abnormal rash irritability feeling hot musculoskeletal stiffness erythema flushing somnolence product administered to patient of inappropriate age loss of personal independence in daily activities
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na